Don’t miss our co-founder Sam Sinai's talk at #GTC2025! Sam will share Dyno’s latest progress on LEAP—our technology bridging foundation models and therapeutic impact—and demo DynoFold, a new AI model powered by NVIDIA AI that efficiently predicts protein dynamics directly from sequence.
Dyno Therapeutics
生物技术研究
Watertown，Massachusetts 19,607 位关注者
We build AI-powered gene therapies.
关于我们
Building high-performance genetic technologies that transform patient lives.
- 网站
-
https://www.dynotx.com
Dyno Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Watertown，Massachusetts
- 类型
- 私人持股
- 创立
- 2018
- 领域
- AAV engineering、Machine learning、Synthetic biology、NGS、Data science、Gene Therapy、Genome Editing、AAV、Software Engineering和Protein Engineering
地点
-
主要
获取路线
343 Arsenal St
Suite 101
US，Massachusetts，Watertown，02472
Dyno Therapeutics员工
动态
-
?? We’re Hiring: Machine Learning Research Scientist @ Dyno Therapeutics ?? ?? Big data. Breakthrough biology. Real patient impact. ?? Use cutting-edge ML to engineer the future of gene therapy. ?? Work with one of the world’s most unique in-vivo protein datasets. ?? Build + deploy models that push the boundaries of biological sequence design. ?? PhD | Python | PyTorch | Sequence Modeling | Big Data ?? Watertown, MA ?? Plus collaborate with some of the best leaders like Kathy Lin and Sam Sinai ?? Check out the details linked here: https://lnkd.in/ePqykT-E Ready to build the future of gene therapy with us? Know someone who is? Tag them! #MachineLearning #GeneTherapy #BiotechCareers #MLResearch #DynoTx #NowHiring #FutureOfMedicine #BostonBiotech #ProteinDesign #MLDesign #DeepLearning
-
Our CEO Eric Kelsic sat down with NYSE to share his thoughts about where the future of healthcare is heading, and what it means for gene therapy patients.? ???https://lnkd.in/eFAXna7R
We're Cure(ious) About the Future of Healthcare. They shared their insights. Part 1: https://lnkd.in/e4-BQKX2?? Part 2: https://lnkd.in/eFAXna7R Featuring: Ali Madani, Profluent, Amit Etkin, Alto Neuroscience, Dr Chris Mansi, Viz.ai, Colin Hill, Aitia, Daphne Haim-Langford, PhD, Tarsier Pharma, Eric Kelsic, Dyno Therapeutics, Joe DeVivo, Butterfly Network, Inc., Dr. Judy Chou, AltruBio Inc., Maha Radhakrishnan, Sofinnova Investments , Munjal Shah, Hippocratic AI, Noubar Afeyan, Flagship Pioneering, Peyton Howell, Parexel, Sheila Gujrathi, MD, Biotech CEO Sisterhood, Thijs Spoor, Perspective Therapeutics, Viswa Colluru, PhD, Enveda
-
Pleased to share that our CEO and cofounder, Eric Kelsic, was highlighted among the Top 50 Healthcare AI Entrepreneurs of 2025 ?? https://lnkd.in/gx5UJrSZ
-
?? Tune in to this Nucleate podcast for an in-depth chat with Dyno Founder & CEO Eric Kelsic and Sam Kessel MD, MBA including a conversation about Dyno’s origins, and how collaboration and curiosity are essential to identifying high-impact scientific projects.
?? Revolutionizing Gene Therapy with AI-Powered Capsid Engineering What happens when you combine physics, systems biology, and machine learning to tackle one of the biggest challenges in gene therapy? You get Dyno Therapeutics—a company pioneering AI-driven capsid engineering to improve gene delivery and make therapies more effective and accessible. In this latest episode with Sam Kessel MD, MBA, Eric Kelsic, CEO and co-founder of Dyno, shares his journey: ?? How his physics and systems biology background shaped his approach to solving biological problems ?? Lessons learned from working in George Church’s lab at Harvard ?? How Dyno uses machine learning to engineer better AAV capsids ?? Using the scientific method to approach business development Kelsic’s story is a masterclass in identifying high-impact problems, leveraging cutting-edge technology, and translating scientific insights into therapeutics to improve patient’s lives. Check out the full episode to dive into the future of AI-powered gene therapy! ???? https://lnkd.in/gt6TDTZY #GeneTherapy #AI #Biotech #Innovation #MachineLearning
-
Dyno’s co-founder and head of machine learning Sam Sinai will be at #PMWC25 in Santa Clara next week to give a talk on AI's transformative potential in biologics, using case studies from the past decade to highlight the challenges and opportunities of achieving real world therapeutic impact with AI methods. Don’t miss it!
-
-
Our thanks to Fay Lin, PhD at Genetic Engineering & Biotechnology News for covering our Roche announcement. As our CEO Eric Kelsic mentioned,?"right now, we’re known as experts in delivery as an AAV platform but the technologies are much more generalizable [...] We can point to our success in capsids and help other biopharma partners understand how they can make use of the capabilities that we spent several years developing."
JPM: Roche Licenses Dyno Therapeutics' AAV Vector for Neurological Gene Therapy Kicking off J.P. Morgan week, Dyno Therapeutics announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological disease. Read more of this reporting from GEN Biotechnology's Fay Lin, PhD. #JPM2025
-
Great to be recognized by Pharmaceutical Technology's Excellence Awards for our work in gene therapy! ???? Check it out here: https://lnkd.in/e_gh2EQn
-
We’re excited to announce that Roche has exercised its option to license one of our next-generation AI-designed AAV vectors for neurological diseases! ???? More on this key milestone for AI in gene therapy: https://lnkd.in/eYKxccMq
-
-
Great to be featured among the 100 cell and gene therapy leaders to watch in 2025 by Drug Discovery & Development. We’ll see you in the new year! ???? https://lnkd.in/eX_n42mb